Pharma retail mkt growth declines 7% month-on-month

Written by fe Bureaus | Updated: Oct 30 2009, 04:53am hrs
Even as most domestic pharma companies are basking in the glow of better than expected quarterly results, the domestic pharma secondary sales market has witnessed a month-on-month dip of 7% in value growth figure. The pharma retail market recorded a growth of 9.8% in September, compared to a growth of 16.5% in August, according to market reflection of ORG IMS. The turnover of the pharma industry for September stood at Rs 3,554 crore. In the products category, there is a major rejig with the onset of early winter. Piramal Healthcares Phensedyl Cough drug jumped eight places in one month time to grab the topmost position, while another coughsyrup, Pfizers Corex is sitting comfortably at the number two position. Another product, a painkiller, Novartis flagship drug in India Voveran, which is a consistent performer was ranked at number two.